Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01657422 · ClinicalTrials.gov registry record · NA
PACE+: Counseling Adolescents for Exercise and Nutrition
A NA study, sponsored by University of California, San Diego.
- Completed
- Registry status
- NA
- Development phase
- 819
- Enrollment target
NCT01657422: Completed NA study, sponsored by University of California, San Diego.
NCT01657422 is a NA study that has completed, run by University of California, San Diego. The registered enrollment target is 819 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (42% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01657422, a NA study, has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- NA
- Development phase
- 819 participants
- Enrollment target
Study Summary
PACE+ was developed to address the increased number of adolescents in our country that are at risk for cardiovascular disease, cancer, and other diseases due to inactivity, obesity, and malnourishment. PACE+ will evaluate the efficacy of an integrated clinical and home-based intervention to improve physical activity and nutrition behaviors in adolescents ages 11-15 over a period of 2 years. This study is unique in that it will be one of the first to evaluate a combined physical activity and nutrition intervention for youth that revolves around the primary health care setting. The PACE+ intervention is particularly innovative in that three components - computer, provider counseling, and an extended home-based intervention - are unified through a common theoretical framework.
Primary Outcome
Equal in importance to the other two primary outcome measures, physical activity and sedentary behaviors
Interventions
- BEHAVIORAL PACE+
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 819 participants |
| Start Date | 2000-08 |
| Est. Completion | 2006-04 |
| Phase | NA |
What the finished NCT01657422 record still lists
NCT01657422 is an interventional study that assigns participants to a tested intervention. The registered 819 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (42% lower).
The record links to 0 conditions, and to 1 intervention - of which PACE+ is the first listed.
NCT01657422 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01657422 about?
NCT01657422 is a clinical study titled "PACE+: Counseling Adolescents for Exercise and Nutrition". PACE+ was developed to address the increased number of adolescents in our country that are at risk for cardiovascular disease, cancer, and other diseases due to inactivity, obesity, and malnourishment. PACE+ will evaluate the efficacy of an integrated clinical and home-based intervention to improve ...
What is the current status of trial NCT01657422?
This trial is currently completed. It is a NA study. The enrollment target is 819 participants. The study started on 2000-08. Estimated completion is 2006-04.
What interventions are being tested in trial NCT01657422?
The interventions under investigation include: PACE+ (BEHAVIORAL).
Who is sponsoring clinical trial NCT01657422?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01657422's enrollment target sits among peer trials
819 134th of 2000 higher than 1,867 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04028687 · 820 participants
MDR - PMCF Study for Taperloc Complete Stems
- NCT04613440 · 820 participants · NA
FaCT Trial (Facilitated Cascade Testing Trial)
- NCT04910269 · 820 participants · Phase 3
Outpatient Treatment With Anti-Coronavirus Immunoglobulin
- NCT04846959 · 818 participants
Study to Evaluate Pregnancy Outcomes in Risankizumab Exposed Pregnancies Relative to Those Non-risankizumab Exposed Pregnancies in Women With FDA Approved Indications
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia